Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial

Gelijkaardige items

• Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study
  door: Alane Izu, et al.
  Gepubliceerd in: (2025-12-01)
• Single priming and a booster dose of 10-valent and 13-valent pneumococcal conjugate vaccine (PCV) maintains suppression of vaccine serotype colonization in South African children at 3, 4, and 5 years of age: a single-centre, open-labelled, randomized trial
  door: Courtney P. Olwagen, et al.
  Gepubliceerd in: (2024-12-01)
• Immunogenicity of Seven-Valent Pneumococcal Conjugate Vaccine Administered at 6, 14 and 40 Weeks of Age in South African Infants
  door: Jones, Stephanie A., et al.
  Gepubliceerd in: (2013)
• Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants,
  door: Madhi, Shabir A., et al.
  Gepubliceerd in: (2012)
• Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status
  door: Madhi, Shabir A., et al.
  Gepubliceerd in: (2017)